Free Webinar - "Decreasing Costs in your Sterile Compounding Operation without Sacrificing Quality" with Eric S. Kastango, MBA, RPh, FASHP - Wednesday, May 9, 2012, 1:00 PM Eastern. Reserve your seat now.
Last week the 2012 USP <797> Compliance Study opened, led by sterile compounding experts and Study Co-Directors, Eric Kastango, RPh, MBA, FASHP, and Kate Douglass, MS, RN, APN,C, CRNI.
First conducted in 2011, the study is the largest and most comprehensive study of USP 797 compliance ever undertaken in the United States. Eric and Kate were able to present their findings from last year's survey in one of our more popular webinars.
The study uses a sophisticated web-based <797> Gap Analysis Tool that Eric and Kate developed and have been using for the last several years. This tool is being made available at no charge to all study participants.
Participants in the study will receive a highly detailed Action Plan that is automatically generated based on the participant's answers to the survey. This Action Plan provides documentation that can be used to begin or continue sterile compounding practice improvements at your location.
The survey takes 60 to 90 minutes to complete but does not need to be completed at one sitting. All individual facility results are confidential - only aggregate data will be used in the study report.
You can register for the study by going to www.797study.com and use Survey Code B797J. The survey closes June 30th.
To swift and safe healthcare, Team Pharmacy OneSource
As a pharmacist, you have options when it comes to where you work, and the team at PharmacyWeek sees several pharmacy job opportunities cross their desks every day that make them want to get up and go work at these dream destinations. Jet Setter Pharmacist highlights great job openings in even better locations, and what makes these locations and employers so unique!
Orchid Pharma Gets FDA Nod For Olanzapine Tablets ANDA RTT News
India's Dr Reddy's gets U.S. nod for osteoporosis drug Reuters
FDA approves generic epilepsy drug from Acella Drug Store News
FDA approves Meda allergy combo Dymista Pharma Times
4. CDC Restates Position on Use of Single-Dose and Single-Use Vials
In an effort to ensure clinicians are clear about the Centers for Disease Control and Prevention (CDC) guidelines, the agency is restating its position on the use of single-dose/single-use vials and also seeks to dispel inaccuracies being disseminated to healthcare providers. Get the full story from Infection Control Today.
5. Chicken Scratches vs. Electronic Prescriptions
As e-mail and texting have become our favored means of written communication, handwriting has almost disappeared. Penmanship is becoming a modern form of hieroglyphics, intelligible only to literary scholars. Get the full story from The New York Times.
6. Discussion: Pharmacy Practice - Clean room remodel
"We are in the beginning stages of planning a remodel of our IV room. Do you have any suggestions for where to begin? Things to consider?" (read entire post/reply)
7. Top News Story Last Week: FDA may let patients buy drugs without prescriptions
In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription. View last week's news review.
SODIUM CHLORIDE
MORPHINE SULFATE
ALTUZAN
E-mail This Newsletter to a Friend
